Vertex Pharmaceuticals’ year-to-date stock performance.
Vertex Pharmaceuticals: “This company is doing the lord’s work…I think it should be bought.”
CME Group’s year-to-date stock performance.
CME Group: “It is one of the most consistent, great companies…It is a strong buy.”
T. Rowe Price Group’s year-to-date stock performance.
T. Rowe Price Group: “I think it’s such a great company…I want to buy the stock.”
Micron: “Enough with the selling of MU.”
Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram
Questions, comments, suggestions for the “Mad Money” website? [email protected]